Smith & Nephew reports executive share award vesting
Smith & Nephew plc reported a management share-based compensation event under its Global Share Plan 2020 and Restricted Share Plan 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Smith & Nephew plc reported a management share-based compensation event under its Global Share Plan 2020 and Restricted Share Plan 2024. On 12 August 2026, performance share awards granted in 2023 vested, with some shares sold solely to cover tax liabilities.
For Rohit Kashyap, President, Advanced Wound Management and Global Commercial Operations, 23,202 US$0.20 ordinary shares vested at a price of £11.096264 per share, of which 9,163 shares were sold and 14,039 shares were retained. The transaction took place on the London Stock Exchange. The company states that remaining unvested shares under the awards have lapsed.
Key Figures
Key Terms
Market Abuse Regulation regulatory
persons discharging managerial responsibilities regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Smith & Nephew (SNN) disclose in its 12 August 2026 Form 6-K?
Which regulations governed Smith & Nephew’s (SNN) disclosure of this PDMR transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.